Home / World / World Lifestyle / Archive by category Health & Medical (Page 20)

Archive by category Health & Medical

Mediktor Acquires Sensely and Consolidates Its Position as a Leader in AI Healthcare Solutions

BARCELONA, Spain and SAN FRANCISCO, June 05, 2024 (Korea Bizwire) – Mediktor, the leading digital healthcare company, has announced the acquisition of Sensely, a San Francisco-based, digital healthcare provider that pioneered an empathy-driven conversation platform to support hospital systems and insurance services with world-class member engagement. This consolidation of two world-leading artificial intelligence-driven solutions providers marks a [...]

Dr. María José Torres, Head of the Allergology Department of the HRU of Malaga, New President of the EAACI

VALENCIA, Spain, June 04, 2024 (Korea Bizwire) – The Closing Ceremony of the EAACI Congress 2024, a meeting forum for experts in Allergy and Immunology from countries all over the world, has taken place. At the closing of the Congress, Dr. María José Torres, Professor of Medicine and Head of the Allergology Service of the Regional [...]

Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer

PHILADELPHIA, PA, June 04, 2024 (Korea Bizwire) – Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive. Antibody therapies called bispecific T cell engagers (BTEs) have emerged as effective treatments for some blood cancers [...]

Deep Integration of Proven AI Tools into Philips Cardiovascular Ultrasound Systems to Better Diagnose More Cardiac Disease Patients

New FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds First fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for [...]

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

DURHAM, N.C., June 04, 2024 (Korea Bizwire) – Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building [...]

Novotech Launches Dedicated Early Phase Unit for Biotechs Leveraging the Australian and New Zealand Clinical Environment

SAN DIEGO, June 03, 2024 (Korea Bizwire) – Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, today announced the launch of a dedicated early phase unit focussed on leveraging the unique advantage of Australian and New Zealand (ANZ) for [...]

BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation

The state-of-the-art instrumentation will support and accelerate BioPharmaSpec’s clients’ efforts in successful biologics product development MALVERN, Pa. and ST. SAVIOUR, Jersey, June 03, 2024 (Korea Bizwire) — BioPharmaSpec (“BioPharmaSpec”), the leading global Contract Research Organization (CRO) for discovery and preclinical characterization of biopharmaceuticals, has made major new investments in instrumentation, including top-of-the-range Mass Spectrometers, to [...]

EAACI Congress Kicks Off in Valencia, Spain

Precision Medicine, Immunotherapy, and Artificial Intelligence (AI) as Key Topics VALENCIA, Spain, May 31, 2024 (Korea Bizwire) – The EAACI International Congress has commenced with the slogan “Revolutionizing patient care through the power of data science.” Over the next four days, experts will discuss the latest advancements in this impactful area. Allergies, which represent a [...]

Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares

Mont-Saint-Guibert, Belgium – May 31, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/ Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the closing of its previously announced underwritten public offering in the United States, [...]

Biognosys Launches Groundbreaking P2 Plasma Enrichment Technology for Unbiased, Deep Plasma Proteomics at ASMS 2024

The proprietary P2 Plasma Enrichment method leverages a novel single-well, single particle-type enrichment method to achieve market-leading performance for unbiased, deep mass spectrometry-based plasma proteomics P2 now offers excellent quantitation and higher throughput for large-cohort biomarker or drug discovery studies, and clinical, epidemiological or population proteomics research P2 Plasma Enrichment is available as a CRO [...]